Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal dexmedetomidine + butorphanol vs morphine for cancer pain
ChiCTR2500114254Phase 4Recruiting
- Sponsor
- Shandong Provincial Hospital Affiliated to Shandong First Medical University
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in cancer pain comparing Intrathecal butorphanol + dexmedetomidine with Intrathecal morphine (2 arms). Primary endpoint: Pain score (VAS). Started Dec 2025; status: recruiting.
02
Drugs
dexmedetomidinebutorphanolmorphine
03
Conditions
cancer pain
Beyond the preview
Go deeper on ChiCTR2500114254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500114254.